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ABSTRACT
EFFECTS OF TWO HIGH-FREQUENCY PHYSICAL THERAPY
PROGRAMS ON BALANCE, GAIT, FATIGUE, AND QUALITY OF
LIFE IN PEOPLE WITH MULTIPLE SCLEROSIS
Min Liu, M.S.
University of Nebraska Medical Center, 2018

Supervisors: Ka-Chun Siu, Ph.D. and Max J. Kurz, Ph.D.
Multiple sclerosis (MS) is an inflammatory disease involving the inflammation and
demyelination in both brain and spinal cord. MS typically affects people in early
adulthood in the range of 20-40 years old, and most patients with MS experience
symptoms on a daily basis, such as walking difficulties, balance impairment, and fatigue,
which can be disabling and impact the Quality of Life (QOL).
The main purpose of this investigation is to determine if our novel, adaptive, highfrequency physical therapy protocol, compared with the conventional therapeutic exercise
protocol, has the potential to improve participants’ dynamic balance, gait, fatigue, and
overall QOL based on clinical measurement scales. After the completion of this
investigation, we found that both types of protocols with the same high dosage improved
the balance, gait, fatigue, and QOL in people with MS similarly in a clinically relevant
manner. Our results provide evidence that a high-frequency physical therapy intervention
consisting of twice per day and five days per week sessions may be an important
parameter for improving balance, gait, fatigue, and QOL in people with MS.
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Chapter 1 Introduction
Background
Triggered by environmental and genetic factors, multiple sclerosis (MS) is a chronic
immune-mediated disease involving inflammation, plaques, and demyelination in the
central nervous system.1 Clinically, there are four subdivisions of MS, including
Relapsing-Remitting MS (RRMS), Secondary-Progressive MS (SPMS), PrimaryProgressive MS (PPMS), and Clinically Isolated Syndrome (CIS).2 RRMS is
characterized by self-limited acute attacks of neurologic dysfunction developing from
days to weeks. Then most patients experience a recovery of function over the next few
weeks to months. Between attacks, those patients can be clinically stable. The second
type, SPMS, begins as RRMS, but its clinical course is characterized by a steady
deterioration in function unrelated to acute neurologic attacks. Unlike SPMS, the third
one, PPMS starts with a steady increase in disability from the very beginning without
acute attacks. The fourth type, CIS, refers to a first episode of MS-related symptoms
lasting at least 24 hours caused by inflammatory demyelination in the central nervous
system that may or may not continue to develop MS. MS typically affects people in early
adulthood in the 20-40 year range and is two to three times more common in women than
men.3 MS affects approximately 400,000 people in the United States and 2.1 million
people worldwide.4,5 As a costly chronic disease, the total all-cause health care costs
associated with MS including direct and indirect costs ranged from $8,528 to $52,244 per
patient per year in the US.6 Common symptoms of MS include fatigue, gait difficulties,
impaired balance, spasticity, depression, and cognitive impairment.7 Most patients with
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MS experience symptoms on a daily basis, especially balance impairment, which can be
disabling and impact the Quality of Life (QOL).8,9 Although pharmacological
interventions play an important role in the treatment of these symptoms, a physical
rehabilitation approach is also imperative as it may target the dysregulation of the
inflammatory balance in MS, but its effectiveness remains elusive.10
There is increasing evidence to support that exercise training may yield beneficial
effects on the mobility and balance function of individuals with MS.11-13 Exercise training
for MS includes aerobic exercises, resistance exercises, and other nontraditional exercise
training, such as yoga, Tai chi, and Pilates.13-16 Although various exercise training
methods were used, there is no universal model of training for individuals with MS.17 The
frequency of exercise training in existing literature ranged from mild to moderate, with
most experiments conducted between 30-90 minutes per session, 2-4 times per week. For
example, Motl et al.18 performed a combined training therapy with a maximum of 60
minutes in duration and 3 days per week. Others recommended 20-30 minutes of aerobic
exercise more than 3 days per week.19 Collectively, these investigations showed a small
improvement of symptoms in people with MS.11,20 It remains to be established what type
of training method is optimal, how many times a week a person should train, and how
long a training session should last for people with MS.
Previously we conducted two studies using two types of protocols with high frequency
physical therapy and demonstrated that the high frequency of physical therapy protocol
may be beneficial to people with MS in regards to mobility, postural balance, and motor
control of the ankle plantarflexors.21,22 One adaptive physical therapy protocol in our
studies was performed at a higher dosage (two times per day, five days per week as
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compared to more traditional levels of two to three sessions per week), and progressively
challenged the patient’s balance, in hopes of making it more adaptable to unstable
situations. Exemplary therapies include forcing patients to use the more impaired limbs
and directing the patient’s attention towards focusing on how to adapt their movement
patterns. Moreover, the therapeutic dosage in our study (45 minutes per session, twice a
day, 5 days a week for a 6-week period) was larger than previous studies23,24 (typically 24 times per week for 30-60 minutes over a 3-12 week period). We suspected that our
high-frequency physical therapy protocol would have clinically relevant improvements in
gait, balance, fatigue, and QOL in MS as well, based on different clinical measurements.

Purpose
The primary purpose of this investigation is to determine if our novel, adaptive, highfrequency physical therapy protocol, compared with the conventional therapeutic exercise
protocol, has the potential to improve participants’ dynamic balance, gait ability, fatigue,
and overall QOL based on clinical measurement scales. Specifically, the Dynamic Gait
Index (DGI) is used to assess the dynamic walking balance; Twelve-Item MS Walking
Scale (MSWS-12) for gait ability; Modified Fatigue Impact Scale (MFIS) for fatigue, and
Multiple Sclerosis Impact Scale (MSIS-29) for overall QOL.

Research Hypothesis
Hypothesis 1:
Compared with the group who completed traditional therapeutic exercise protocol, the
group that completed novel motor adaptive therapeutic protocol will have greater
improvements in the DGI score after 6 weeks of therapy.
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Hypothesis 2:
The MSWS-12 score will be improved in the group that completed novel motor adaptive
therapeutic protocol than the group who completed traditional therapeutic exercise
protocol after 6 weeks of therapy.
Hypothesis 3:
The group that completed novel motor adaptive therapeutic protocol will improve fatigue,
based on the MFIS score, compared with the group who completed traditional therapeutic
exercise protocol after 6 weeks of therapy.
Hypothesis 4:
The group that completed novel motor adaptive therapeutic protocol will have a
decreased MSIS-29 score than the group who completed traditional therapeutic exercise
protocol after 6 weeks of therapy.
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Chapter 2 Literature Review
Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease in the central
nervous system. Several factors have been proposed to explain the pathogenesis of MS,
including genetic susceptibility, infectious agents, and other environmental factors.
Pathological hallmarks of MS include focal or diffused plagues of demyelination,
inflammation, axonal loss, and neurodegeneration in brain and spinal cord. Over time,
repeated pathological episodes of disease activity in CNS can lead to a wide range of
clinical features of MS, such as weakness, fatigue, gait instability, balance impairments,
cognitive deficits, visual and sensory changes. Such symptoms often result in poor
Qualify of Life (QOL). The clinical characteristics and disability levels vary significantly
among individuals with MS. Kurtzke Expanded Disability Status Scale (EDSS) has been
established and gained its international acceptance to measure MS severity, and it is
graded as mild (0–3.5), moderate (4–5.5) and severe (6–10).25 The EDSS measures the
degree of neurologic impairments within eight functional domains including pyramidal,
cerebellar, brain stem, sensory, bladder and bowel, visual, cerebral and other. There is
increasing evidence that physical therapy or exercise training may have beneficial effects
on people with MS. In this review, we focus on four areas of clinical characteristics to
investigate the effects of physical therapy on MS, based on data from previous clinical
trials as discussed below.

Balance impairment and effects of physical therapy interventions on balance in MS
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One of the primary manifestations in MS patients is the balance impairment. Balance
dysfunction can lead to falls, injury, and reduced activity participation.26 It is estimated
that around 74% of people with MS have difficulty with the balance and 50% of MS
patients felt balance impairment limited their ability to perform activities of daily
living.27 A study also suggests that individuals with MS may even experience motor
function deterioration during the early stages of the disease with no clinical neurologic
signs.28 Balance maintenance requires the interaction of visual, vestibular, and
proprioception processes to generate coordinated movements that maintain the center of
mass within the limits of stability. One study reveals that the delay in postural response is
the result of the slowed somatosensory conduction.29 People with MS have poor
performance in the functional reach test, arm raise test, tandem stance, single-leg stance,
and in response to external perturbation.30 Specifically for standing posture balance,
compared with healthy adults, individuals with MS have decreased ability to maintain
position and have more postural sway, which leads to increased risks of falling.31,32 And
for dynamic balance, people with MS move less far and less quickly towards limits of
stability when trying to reach or step.28,32,33 MS patients also demonstrate reduced center
of pressure displacement during voluntary leaning and reaching.33 Moreover, people with
MS have less ability to control anticipatory and reactive balance. A few studies indicate
that there are trunk control deficits and delayed posture responses to postural
displacements and perturbations, as well as reduced ability to control anterior-posterior
sway in response to these perturbations in people with MS.29,34 Cameron et al. suggests
that the primary cause of imbalance in MS is the result of slowed afferent proprioceptive
conduction in the spinal cord, unlike the imbalance from cerebellar disorders.29
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The Dynamic Gait Index (DGI) is a commonly used tool in rehabilitation settings to
assess dynamic balance while adapting gait to changes in task demands, including gait on
even surfaces, gait while changing speed, gait while performing head turns, stepping
over, or around obstacles, and pivoting during walking and stair climbing. The total score
ranges from 0 to 24. A high score indicates better performance on dynamic balance. A
score of 19 or less has been shown to be associated with higher risk of falls in MS.35,36
The DGI is a reliable tool to assess balance and gait dysfunction in persons with MS,
with inter-rater reliability ranging from .910 to .976, and intra-rater reliability ranging
from .760 to .986.35 It also has excellent criterion validity with other balance scales in
people with MS, such as Timed Up and Go (TUG), Berg Balance Scale (BBS), and
Activities-specific Balance Confidence (ABC).37
There are limited studies determining the therapeutic exercise effects on balance in
MS. Several randomized controlled trials (RCT) demonstrated mixed results on balance
in people with MS through various training exercises, including combined aerobic and
resistance exercise38-40, aquatic training41, and group stability exercise, based on the
standard measures, such as TUG, DGI, BBS, and Functional Reach test (FR).42
Specifically, combined resistance and aerobic training were found to have a small, but
non-significant effect on balance in people with MS.39,40 Specific balance exercises were
also conducted in one RCT. Cattaneo et al.43 demonstrated that specific balance retraining
exercises had a significant effect on balance in individuals with MS, based on the BBS,
but no significant effect observed on the DGI. Another RCT also suggested that the group
exercise program was effective in improving the balance in patients with MS, based on
the BBS.44 The intervention consisted of flexibility, range of motion, strengthening for
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low extremity, core stabilization, balance and coordination, and functional activities, 60
min per session, 3 times a week for 12 weeks.44 Overall, the frequency of the exercise
training in the previous studies ranged from mild to moderate, spreading between 3-10
weeks, 3-8 sessions per week, 30-60 min/session, which has been shown to yield
significant, but small improvements on balance in patients with MS.23 Therefore, the
evidence regarding the beneficial effects of physical therapy interventions on balance in
MS is still weak and it is based on a limited number of non-RCTs and RCTs.

Gait dysfunction and relevant physical therapy interventions in people with MS
Gait abnormalities are common in individuals with MS and associated with increased
likelihood of experiencing falls and reduced quality of life. Gait disturbance can be seen
in early stages of the disease, even identified in patients with the absence of gait
abnormalities on standard clinical examination.45 About 85% of people with MS indicate
gait disturbances as their main complaint.46 A study reported that approximately 33% of
patients with MS had difficulty walking and required assistance at 10 years from the
onset of MS.47 While the exact causes of gait abnormalities observed in MS are yet to be
identified, it is believed that lower extremity weakness, spasticity, and sensory changes
may contribute to the symptoms. People with MS tend to walk slower, have decreased
step length and cadence, spend a greater percentage of a gait cycle in double support, and
demonstrate less joint motion and more variability in gait parameters during gait than
healthy controls.46,48,49 A recent study also revealed that individuals with MS showed
decreased range of motion at the ankle, knee, and hip associated with increased pelvic tilt
and hiking.50 Allali et al. suggested gait analysis, such as stride time variability,
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represents a clinical potential predictor of falls in people with MS with low disability, and
it may be more appropriate than the EDSS in studies focused on fall prevention in MS.51
The 12-item Multiple Sclerosis Walking Scale (MSWS-12) is a MS-specific, patientbased questionnaire to measure the gait ability in individuals with MS in clinical studies
and clinical practice. Each item ranges from 1 to 5, generating total scores ranging from
12 to 60, or transformed scores ranging from 0-100, with the higher the sum is, the more
severe the degree of ambulatory disability. It is a highly valid and reliable scale in
MS.52,53 A study reported that MSWS-12 is significantly correlated with spatiotemporal
parameters of gait in people with MS, suggesting that it is an easily administered and
inexpensive tool for the comprehensive assessment of walking disability in individuals
with MS.54
There is emerging evidence that physical therapy interventions can ameliorate gait
dysfunction in people with MS. Several studies focused on specific interventions for
muscle weakness, spasticity, and reduced gait velocity that contribute to gait
abnormalities in MS, including resistance training, aerobic exercise, and body weightsupported treadmill training (BWSTT).18,55-58 Resistance training has shown to improve
functional mobility based on the 10-meter walk test (10MWT) and 6-minute walk test
(6MWT).57 Resistance training can also improve gait kinematics, including increased step
length, stride length, and foot angle, as well as decreased duration of the double-support
phase.56
Aerobic exercise is another type of training program and it has been shown to
improve walking speed and endurance in patients with MS.58 BWSTT can provide
aerobic training for patients with severe MS who are not able to walk independently on a
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treadmill, and it is suggested that BWSTT may improve walking speed and endurance in
people with severe MS.59 Moreover, ankle foot orthoses and functional electrical
stimulation have been demonstrated to improve the gait pattern of individuals with MS
and to reduce the energy expenditure while walking.60,61 The frequency of interventions
in most aforementioned studies is mild to moderate, ranging from 2-5 times/week, 20-60
minutes/session for 4-8 weeks.
In summary, there is promising evidence supporting that some types of physical
therapy interventions may improve gait/walking abilities in patients with MS. However,
it is insufficient to determine optimal dosage and whether patients can tolerate the highfrequency physical therapy intervention.

Fatigue and related physical therapy interventions in individuals with MS
Fatigue is also considered to be one of the most common symptoms and disabling
features of MS62, with 65-97% of individuals having significant fatigue63 and 15-40%
reporting fatigue as the most disabling symptom.64 Fatigue in MS is an abnormal sense of
tiredness or lack of energy, out of proportion to the degree of effort or level of energy,
which significantly interferes with daily activities. The manifestation of fatigue in MS
includes acute fatigue related to specific muscle groups and global, persistent fatigue
which adversely affects both mental and physical activity.65 Prolonged fatigue associated
with localized muscles may lead to weakness, and it should not be confused with
weakness. There are two different types of fatigue in MS, including mental (central)
fatigue, inability to sustain the central drive to spinal motor neurons, and motor
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(peripheral) fatigue, a loss of force-generating capacity within the muscle itself. MS
fatigue can also be categorized into primary fatigue and secondary fatigue. Primary
fatigue is believed to be directly related to the central nervous system damage specific to
MS, such as demyelination, inflammation, and axonal loss. Secondary fatigue may be
attributed to pain, depression, stress, anxiety, sleep disorders, medication use, and general
deconditioning. The pathophysiology of central fatigue in people with MS is not well
understood and probably related to the demyelination, diffuse cerebral axonal injury,
brain atrophy, reduced cortical metabolic activity, and inflammation.66-68 Two studies
have shown that anatomical and metabolic muscle changes may contribute to the
symptoms of peripheral fatigue in people with MS, including less Type I (fatigue
resistant) fibers, more Type II (fatigable) fibers, decreased fiber size, oxidative capacity
impairments, and slowed excitation-contraction responses.69,70 Both peripheral and
central mechanisms may have some roles in the pathogenesis of fatigue in MS. However,
it is believed that central mechanisms plays a more important role.71 Fatigue may also be
related to gait variability in MS. Sehle et al.72 suggested that gait variability is
significantly correlated with the motor sections of the Fatigue Scale of Motor and
Cognition, but not with the cognitive portion of the scale, which indicates that motor
fatigue is more related to gait variability than mental fatigue. Kalron73 also found that a
fatigued group walked slower, took smaller steps, and had a shorter stride length than
those in a non-fatigued group. However, two other studies reported that there were
minimal associations between fatigue and gait variability during short walks.46,74 There is
also a relationship between fatigue and balance in MS. A study demonstrated that fatigue
was significantly associated with balance as a function of central sensory integration in

12

people with MS.75 Collectively, fatigue is one of the common symptoms of MS. Fatigue
may be associated with other clinical features, such as gait and balance. It is complex and
not fully understood, which warrants further study.
An accurate assessment of fatigue is beneficial to help clinicians and researchers
determine the severity of fatigue. The Modified Fatigue Impact Scale (MFIS) is a clinical
measurement to evaluate fatigue in MS.76 The MFIS is based on items derived from
interviews with patients with MS regarding how fatigue impacts their lives. It consists of
21 items, with each item scoring between 0 and 4, which gives a self-reported
multidimensional measure of fatigue on physical, cognitive, and psychosocial
functioning. The MFIS global score range is between 0 and 84, with a higher score
indicating more fatigue. Reliability and validity of the MFIS have been established in
people with MS and it has been recommended as an outcome measure for use in MS
research and clinical practice.77
The treatment of fatigue mainly includes pharmacologic and non-pharmacologic
therapies. There are a few medications, including Amantadine, Modafinil, and
Armodafinil, which may mitigate the fatigue symptom in persons with MS, however, no
effective medicine has been found.68 On the other hand, therapeutic exercise may be an
alternative way to reduce fatigue and appears to be more effective in improving fatigue
compared to the pharmacological agents.78 A recent Cochrane systematic review
demonstrated that exercise therapy is a promising way to reduce fatigue without harm in
patients with MS, based on the results of the 45 RCTs.24 The frequency in these studies is
relatively low to moderate, ranging from 30 to 60 minutes per session, 2 to 5 times per
week, with the duration of the interventions ranged from 8 to 12 weeks.24 A few studies
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also explored the effects of high intensity exercises on people with MS.57,79-83 A recent
exploratory study suggested that high-intensity resistance training is associated with
clinical improvements in fatigue in people with relapsing remitting multiple sclerosis,
possibly through its positive effects on decreased pro-inflammatory cytokine levels.81
This high-intensity intervention was performed twice a week, 60 min per session for 12
weeks, with a 5 min warm-up, three lower body exercises, four upper body exercises, and
one whole body exercise in each training.81 One RCT also showed that 12 weeks of
high-intensity aerobic training combined with resistance training was safe and well
tolerated, with improved muscle strength and endurance capacity in MS.82 However,
another RCT revealed that the standard training including aerobic exercises, lower
extremity stretching, upper extremity strength training, and balance exercises, with the
addition of high-intensity eccentric muscle training, was not superior to the standard
training alone, regarding fatigue, balance, and gait assessments, after the intervention of
45-60 min per session, 3×/week for 12 weeks.83 Collectively, some types of exercise
training may improve symptomatic fatigue in persons with MS, but the optimal
therapeutic paradigm to treat the MS-related fatigue is still yet to be determined.

Quality of Life (QOL) and related physical therapy interventions in MS
QOL is an umbrella term that includes social, emotional, physical, economic and cultural
dimensions of our lives. There is emerging evidence that QOL is compromised in patients
with MS.84,85 Several factors, including physical disability status, fatigue, depression, age,
sex, and socioeconomic status, have been found to be associated with lower QOL in
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people with MS than healthy populations or patients with other chronic diseases.86
Statistical results have shown that the unemployment rate is up to 70% in communitydwelling individuals with MS, and half of them due to the MS consequences.87 After the
initial diagnosis, at least a third of MS patients experience a significant decline in their
standard of living.88 Compromised QOL in MS is also associated with the severity of the
disease, which has been found to correlate with high economic burden to society.89
Therefore, it is imperative for clinicians to find a way to improve QOL in patients with
MS.
The Multiple Sclerosis Impact Scale (MSIS-29)90 is one of the most common
questionnaires to measure QOL in people with MS. It is a twenty-nine item, diseasespecific scale to access the impact of MS from the patient’s perspective. It consists of 20
physical items and 9 psychological items that may impact individuals with MS. This is
consistent with the definition of health-related QOL incorporating both psychological and
physical components.91 The MSIS-29 ranges between 29 and 145, with higher scores
indicating greater impact or a poor quality of life. It is a valuable outcome measurement,
used not only in cross-sectional studies but also in intervention studies to monitor MS
progression.92 A minimal change of 8 points in the MSIS-29 indicates clinical
significance.93
Exercise training is a promising intervention for improving QOL in MS. Fatigue,
disability, depression, pain, social support, and self-efficacy act as intermediary roles
between physical training and QOL.94 There is cumulative evidence supporting that
physical exercise is associated with a small improvement in QOL in people MS.95
However, the parameters of the exercise training protocols on QOL, such as the type of
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exercise training, the length of the intervention, and the amount of the training per week,
vary considerably in existing literatures. A study reports that there is a significant effect
for aerobic exercise on improving QOL in MS, but not for non-aerobic exercise or
aerobic and non-aerobic exercise combined.95 Exercise training interventions of < 3
months and interventions of ≥ 3 months both are associated with significant
improvements in QOL, but shorter duration of interventions are associated with greater
effects.95 This research also suggests that exercise training greater than 90 minutes per
week yields greater effects on QOL than that of less than 90 minutes per week.95 Thus,
various exercise training protocols and small treatment effect on QOL underscore the
importance of establishing the optimal therapeutic paradigm to improve QOL in MS.

Summary
In summary, there is supportive, but not overwhelming evidence for a beneficial effect
of physical therapy and exercise training on gait, balance, fatigue, and QOL. The average
duration of the existing training protocols was 60 minutes per session (30-90) lasting
9 weeks (range 3–24) with a mean frequency of 3 sessions per week (range 2–6). Existing
physical therapy training protocols include resistance exercise, aerobic exercise,
combined aerobic and resistance training, and alternative interventions, such as aquatics,
yoga, Tai chi, etc. The participants in the majority of existing clinical trials have mild to
moderate level of disability based on the EDSS. In spite of the emerging evidence
supporting the beneficial effects of physical therapy interventions on gait, balance,
fatigue, and QOL in people with MS, the heterogeneity of protocols and participant
samples with various levels of severities in previous studies raises questions regarding the
optimal components and frequency of training, such as type of exercises, optimal
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duration of training, and number of sessions required to elicit significant and clinically
relevant improvements. Our previous investigations showed that a high frequency of
physical therapy was beneficial to people with MS in regards to walking speed, step
length, walking endurance, postural balance, and motor control of the ankle
plantarflexors21,22. We suspected that our high-frequency physical therapy protocol would
have clinically relevant improvements in gait, balance, fatigue, and QOL in MS as well,
based on different clinical measurements.
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Chapter 3: Manuscript
Introduction
Multiple sclerosis (MS) is an inflammatory disease involving the inflammation and
demyelination in both brain and spinal cord.1,96 MS typically affects people in early
adulthood in the 20-40 year range and is two to three times more common in women than
men.3 MS affects approximately 400,000 people in the United States and 2.1 million
people worldwide.4,5 As a costly chronic disease, the total health care costs associated
with MS including direct and indirect costs ranged from $8,528 to $52,244 per patient per
year in the US.6 Common symptoms of MS include fatigue, gait difficulties, impaired
balance, spasticity, depression, and cognitive impairment.7 Most patients with MS
experience symptoms on a daily basis, especially balance impairment, which can be
disabling and impact the Quality of Life (QOL).8,9 Although pharmacological
interventions play an important role in the treatment of these symptoms, physical
rehabilitation approach is also imperative as it may target the dysregulation of the
inflammatory balance in MS, but its effectiveness remains elusive.10
There is increasing evidence to support that exercise training may yield beneficial
effects on the balance and mobility function of individuals with MS.11-13 Exercise training
for MS includes aerobic exercises, resistance exercises, and other nontraditional exercise
training, such as yoga, Tai chi, and Pilates.13-16 Although various exercise training
methods were used, there is no universal model of training targeting specific impairment
in individuals with MS, and it is typically driven by personal preferences.17 The
frequency of exercise training in existing literature ranged from mild to moderate, with
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most experiments conducted between 30-90 minutes per session, 2-4 times per week. For
example, Motl et al.18 performed a combined training therapy incorporating aerobic,
resistance, and balance exercises with a maximum of 60 minutes in duration and 3 days
per week. Others recommended 20-30 minutes of aerobic exercise more than 3 days per
week.19 Collectively, these investigations showed a small improvement of symptoms in
people with MS.11,20 It remains to be established what is the optimal exercise regimen,
such as what type of training method is best, how many times a week a person should
train, and how long a training session should last for people with MS.
Previously we conducted studies using two types of protocols with high frequency
physical therapy and demonstrated that the high frequency of physical therapy protocol
may be beneficial to people with MS in regards to mobility, postural balance, and motor
control of the ankle plantarflexors.21,22 One adaptive physical therapy protocol in our
studies was performed at a higher dosage, and constantly challenged the patient’s
balance, in hopes of making it more adaptable to unstable situations. Exemplary therapies
include forcing patients to use the more impaired limbs and directing the patient’s
attention towards focusing on how to adapt their movement patterns. Moreover, the
therapeutic dosage in our study (45 minutes per session, twice a day, 5 days a week for a
6-week period) was larger than previous studies23,24 (typically 2-4 times per week for 3060 minutes over a 3-12 week period). We anticipated that our high-frequency physical
therapy protocol would have clinically relevant improvements in gait, balance, fatigue,
and QOL in MS as well, based on different clinical measurements.
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Methods

Participants
Thirty-three participants were recruited from the University of Nebraska Medical
Center’s (UNMC) MS clinic with the following inclusion criteria: between 30-70 years
old, a Kurtzke Expanded Disability Status Score (EDSS) of 3.0-6.5, a definitive diagnosis
of MS, able to walk on a treadmill at a minimum speed of 0.5 miles per hour while
holding onto handrails, cognitively competent, and a Mini-Mental State Examination
score of >21. The exclusion criteria were: documented MS-related relapse in the previous
six months, major MS-specific medication changes in the previous three months, and the
presence of another major co-morbidity such as neurological disorders, uncontrolled pain,
hypertension, and diabetes. The study was reviewed and approved by the UNMC
Institutional Review Board, and all participants provided written consent (clinical trial
registration No.: NCT02524483). The participants were pseudo-randomly assigned to
either a motor adaptation cohort (MAC) or a therapeutic exercise cohort (TEC) upon
enrollment. The pseudo-random assignments were performed such that a participant
meeting the inclusion criteria was randomly placed in one of the intervention groups, and
a second participant with a similar EDSS was assigned to the other group. All
participants were blinded to therapeutic intervention allocations throughout the study.
Interventions
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The total intervention period for both cohorts was six weeks. The therapy was performed
twice a day for five consecutive days each week. The initial two weeks were conducted
under close supervision of a physical therapist (HR, BC, or KV). The remaining four
weeks were performed by the patient at their home and were monitored weekly via
teleconferences with the therapist. Subjects completed the same activities at home as they
did during the initial two weeks and kept a home exercise program log book to track their
activity.
Motor Adaptation Cohort (MAC)
The motor adaption session included warm-up, balance training, treadmill and
overground walking training. The warm-up lasted 5 minutes, including several repetitions
of movements, stretches, and coordination activities for the trunk and limbs.
After the warm-up, the participant proceeded with a 20-minute balance-training
program one-on-one with the therapist according to the initial assessment. The balance
training program included a sitting/standing balance training, such as sitting on a gym
ball or standing in a corner with the feet either on the floor or a piece of foam while
keeping eyes closed. The purpose of this training was to challenge and progress the
participant’s balance gradually to maintain upright control despite altered visual and
somatosensory inputs. For instance, the starting position might be less challenging for the
first 5 minutes on the foam with their feet 10 inches apart, then progressing to more
challenging positions during next 5-minute periods, and finally returning to a less
challenging position for the final 5 minutes. During the training, verbal and tactile cues
were provided for upright posture and relaxation of tense body parts, and verbal cues for
the increase of sensory awareness (i.e., location of pressure on the soles of feet). The
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therapist also observed the participant for the ability to meet the task’s demand (i.e., the
number of touches to the wall). The therapist would increase the demands of postural
training according to their observations of the participants. In general, no rest periods
occurred during the balance sessions. During the balance exercises, the participant was
provided with a table or chair in front for temporary support if necessary, and each
participant wore a gait belt for balance assistance as needed.
Lastly, the participant completed a 20-minute challenging treadmill and overground
walking training. The treadmill training consisted of tasks such as forward, backward, or
sideways walking with a harness provided as needed for safety. The use of handrails, the
degree of ramp incline, and the treadmill speed were tailored to each participant during
the training to provide an appropriate level of intensity. In addition, the therapist provided
overground training indoors with varied walking direction, speed, using a less-supportive
assistive device than they were accustomed to, and/or increasing dynamic balance
activities. The therapist provided verbal and tactile cues, as well as visual feedback by
training in front of a mirror to help participants establish a more normal gait pattern. A
protocol similar to that described above for the balance task was used to progress each 5minute locomotor training period. Participants were provided with short rest periods as
needed. The intensity of the activities was increased as tolerated based on each
participant’s level of performance and fatigue during the previous session.
Therapeutic Exercise Cohort (TEC)
Each therapeutic exercise session included 15 minutes of strength and flexibility
exercises, 15 minutes of balance exercises, and 15 minutes of treadmill walking
performed in a small group setting (3 subjects). The activities selected for the therapeutic
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program were similar to those that would be performed in a group exercise program.
Subjects were instructed to complete each task at their own pace for 3 minutes with the
therapist supervising. Strength exercises consisted of activities such as forward/backward
lunges, stepping up/down a step, and squats. Flexibility training was performed both
standing up and lying on a mat. Subjects were taught how to stretch the lower extremity
muscles, especially any muscle that was specifically problematic to them. Both static and
dynamic balance exercises were completed in each session. Static balance exercises
included standing on a piece of foam with eyes open and feet wide apart, or standing on
one leg as long as possible with support. Dynamic balance exercises included stepping
over small obstacles, walking sideways, or walking heel to toe. For treadmill walking, the
subjects were encouraged to remove one or both hands from the handrails if possible. The
participants were allowed to increase and decrease their speed as needed to accomplish
the total time. All subjects reported their rate of perceived exertion based on the Borg
scale, and were instructed to attempt to work at a score of 12 or 13, which indicates that
the exercise was somewhat hard. Rest was given as needed throughout the entire session.

Outcome measures & Clinical assessments
For both MAC and TEC, all measurements were assessed at the baseline, as well as at the
end of week 2 and week 6 of the investigation.
Balance assessment
The Dynamic Gait Index (DGI) was used to assess dynamic balance while adapting gait
to changes in task demands, including gait on even surfaces, gait while changing speed,
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gait while performing head turns, stepping over, or around obstacles, and pivoting during
walking and stair climbing. The total score ranges from 0 to 24. A high score indicates
better performance on dynamic balance. A score of 19 or less has been shown to be
associated with higher risk of falls in MS.35,36 DGI is a reliable tool to assess balance and
gait dysfunction in persons with MS, with inter-rater reliability ranging from .910 to .976,
and intra-rater reliability ranging from .760 to .986.35 In this clinical trial, the scoring was
performed by one researcher (ML) after watching the DGI testing videos in two testing
sessions 5 days apart. The test-retest reliability was 0.87, which was calculated by a third
person (BD).
Gait assessment
The 12-item Multiple Sclerosis Walking Scale (MSWS-12) is a self-report questionnaire
to measure the gait ability in individuals with MS. Each item ranges from 1 to 5,
generating total scores ranging from 12 to 60, or transformed scores ranging from 0-100,
with the higher the sum indicating more severe ambulatory disability. It is a valid and
reliable scale in MS.52,53 A study reported that MSWS-12 is significantly correlated with
spatiotemporal parameters of gait in people with MS, suggesting that it is an easily
administered and inexpensive tool for the comprehensive assessment of walking
disability in individuals with MS.54
Fatigue assessment
The Modified Fatigue Impact Scale (MFIS) was used to evaluate the patients’ fatigue.76
The MFIS is based on items derived from interviews with patients with MS regarding
how fatigue impacts their lives. It consists of 21 items, with each item scoring between 0
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and 4, which gives a self-reported measure of fatigue on physical, cognitive, and
psychosocial functioning. The MFIS global score range is between 0 and 84, with a
higher score representing more fatigue. Reliability and validity of the MFIS have been
established in patient with MS.77 It has been recommended as an outcome measure for
use in MS research and clinical practice.77
Quality of Life (QOL)
The Multiple Sclerosis Impact Scale (MSIS-29)90 is twenty-nine item scale to measure
QOL or impact of MS from the patient’s perspective. It consists of 20 physical items and
9 psychological items that impact individuals with MS. The MSIS-29 ranges between 29
and 145, with higher scores indicating greater impact or a poor quality of life. It is a
reliable and valid measure of disease impact.97 A minimal change of 8 points in the
MSIS-29 indicates clinical significance.93

Statistical analysis
Descriptive statistics were used to summarize participant characteristics. Initially,
independent samples t tests and/or chi-square tests were used to compare the baseline
characteristics of the MAC and TEC groups. Then, we conducted a series of mixeddesign analysis of variance (ANOVA), which were performed for each outcome measure
to assess differences across time (2 and 6 weeks) and between study groups, and for the
interaction between time and study group. For the mixed-design ANOVA, the
assumptions of sphericity and homogeneity of the variances were tested using Mauchly
and Levene tests. The Huynh-Feldt correction was applied if there was a violation of the
sphericity assumption. All statistical analyses were performed using IBM SPSS Statistics
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22 statistical software (IBM Corp., Armonk, NY, USA). Data were plotted with
GraphPad PRISM software (GraphPad Software Inc., San Diego, Calif.). Statistical
significance was set at P≤0.05. Cohen’s d was also used to assess the effect size, which
was interpreted as small (d= 0.2), medium (d = 0.5), and large (d = 0.8), respectively.98

Results
A total of 43 potential subjects with MS were assessed for eligibility (Figure 1). Ten
people were excluded because they did not fit the inclusion criteria. The remaining 32
individuals with relapsing-remitting or secondary progressive MS met the inclusion
criteria and were assigned to either group. In the MAC, two subjects were withdrawn
from the study due to noncompliance to the study procedures. In the TEC, one individual
discontinued due to a non-MS related health condition, and one individual discontinued
due to a fall-related injury that occurred during the training program. At the end of the
intervention period, 15 individuals in the MAC (Mean Age ± SD: 52.60 ± 8.72 years, 9
Females; mean EDSS score, 5.43 ± 0.94) and 13 individuals in the TEC (Mean Age ±
SD: 54.77 ± 9.27 years, 6 females; mean EDSS ± SD, 5.26 ± 0.95) completed the entire
six weeks of their respective programs and were included in the analyses. Table 1
summarizes the characteristics of the subjects between the MAC and TEC at baseline. No
statistically significant between-group differences for any variables, including age, sex,
MS type, MS duration, EDSS, MSWS-12, MFIS, and MSIS-29, were found at baseline,
except DGI (p=0.04). At the end of home-based training, participants from both MAC
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and TEC had a compliance rate of ≥92%, according to home exercise log book
information.

Figure 1. Flowchart of enrollment procedure
43 subjects screened for eligibility
EDSS and Mini-Mental State Exam
10 subjects excluded
9 – EDSS < 3.0
1 – unable to walk on
treadmill
33 subjects enrolled

15 subjects pseudo-randomly
assigned to the Therapeutic Exercise

2 subjects discontinued
- 1 for non-MS related health
complication
- 1 for fall-related injury
13 subjects completed
the therapy

18 subjects pseudo-randomly
assigned to the Motor Adaptation

3 subjects discontinued
- 2 for non-compliance
- 1 for non-MS related
health complication
15 subjects completed
the therapy
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Table 1 Baseline Characteristics of the Study Participants
Characteristics

MAC (n=15)

TEC (n=13)

P-value

Age (years)

52.60 ± 8.72

54.77 ± 9.27

0.83

Sex (% female)

46.2%

60%

0.46

MS type (% RRMS)

69.2%

73.3%

0.81

MS duration (years)

15.53 ± 6.21

12.23 ± 5.54

0.69

EDSS

5.43 ± 0.94

5.26 ± 0.95

0.91

DGI

13.00 ± 3.95

15.85 ± 2.58

0.04*

MSWS-12

46.53 ± 8.36

41.23 ± 9.40

0.13

MFIS

71.40 ± 26.59

54.08 ± 42.85

0.20

MSIS-29

81.13 ± 19.64

71.54 ± 26.98

0.29

Note: values are mean ± SD or percentage. * Indicates significant difference (p < 0.05)
Abbreviations: MAC: motor adaption cohort; TEC: therapeutic exercise cohort; MS:
multiple sclerosis. RRMS, relapsing-remitting multiple sclerosis; EDSS: Kurtzke
expanded disability status scale; DGI: dynamic gait index; MSWS-12: 12-item
multiple sclerosis walking scale; MFIS: modified fatigue impact scale: MSIS-29:
multiple sclerosis impact scale.

Balance measures
There was a significant pre/post main effect (increase in the composite DGI scores) from
baseline to the end of 2-week training (14.42 ± 3.39 vs. 17.53 ± 3.13, respectively) (p <
0.001; Cohen’s d = 0.95), as well as from baseline to the end of 6-week training (14.42 ±
3.39 vs. 18.62 ± 2.77, respectively) (p <0.001, Cohen’s d = 1.36) (Fig 2, Table 2).
Moreover, there was a statistically significant difference regarding the composite DGI
score between 2-week training and 6-week training (17.53 ± 3.13 vs. 18.62 ± 2.77,
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respectively)

(p = 0.001, Cohen’s d = 0.37). However, there was no significant

interaction between time and group (p = 0.243), indicating both groups improved their
dynamic balance similarly (Fig 2).
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Figure 2: Mean changes in the DGI raw score at 2 and 6 weeks. DGI: Dynamic Gait Index; TEC:
Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 0.05
Table 2: Outcome measures for all participants before and after receiving MAC or TEC (Mean, SD, and
95% CI)
Outcome

Baselin
e level,
mean
(SD)

DGI (range, 0-24)
MAC
13.00
(n=15)
(3.95)
TEC
15.85
(n=13)
(2.57)
Composit 14.42
e result
(3.39)

2-week
level,
mean
(SD)

6-week
level,
mean
(SD)

16.67
(3.24)
18.38
(2.99)
17.53
(3.13)

18.00
(2.73)
19.23
(2.77)
18.62
(2.77)

MSWS-12 (range, 12-60)
MAC
46.53
35.00
(n=15)
(8.36)
(11.83)
TEC
41.23
34.85
(n=13)
(9.40)
(8.51)
Composit 43.88
34.92
e result
(8.87)
(10.46)
MFIS (range, 0-84)

32.20
(8.74)
30.92
(7.85)
31.56
(8.37)

2-week postintervention
effects (change
from the baseline)
Mean
P value
differenc
e (95%
CI)

6-week postintervention
effects (change
from the baseline)
Mean
P value
differenc
e (95%
CI)

6-week postintervention
effects (change
from the 2-week)
Mean
P
differenc value
e (95%
CI)

3.10
(1.70,
4.51)

<0.001
*

4.192
(2.72,
5.67)

<0.001
*

1.09
(0.40,
1.78)

0.001
*

-8.96 (13.65, 4.27)

<0.001
*

-12.32 (16.50, 8.14)

<0.001
*

-3.36 (7.17, 0.45)

0.097
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MAC
(n=15)
TEC
(n=13)
Composit
e result

71.40
(26.59)
54.08
(42.85)
62.74
(35.14)

43.60
(26.00)
39.54
(25.69)
41.57
(25.92)

36.07
(21.79)
24.46
(17.61)
30.26
(20.02)

MSIS-29 (range, 29-145)
MAC
81.13
60.20
(n=15)
(19.64) (16.47)
TEC
71.54
54.69
(n=13)
(26.98) (14.31)
Composit 76.34
57.45
e result
(23.38) (15.55)

59.27
(18.06)
52.61
(12.51)
55.94
(15.78)

-21.17 (32.39, 9.95)

<0.001
*

-32.47 (47.33, 17.62)

<0.001
*

-11.31 (20.45, 2.16)

0.012
*

-18.89 (27.84, 9.94)

<0.001
*

-20.40 (30.95, 9.84)

<0.001
*

-1.51 (8.51,
5.50)

1.000

* Indicates significant difference (p < 0.05)
Abbreviations: MAC: motor adaption cohort; TEC: therapeutic exercise cohort; MS: multiple sclerosis.
DGI: dynamic gait index; MSWS-12: 12-item multiple sclerosis walking scale; MFIS: modified fatigue
impact scale: MSIS-29: multiple sclerosis impact scale.

Gait measures
There was a significant pre/post main effect (decrease in the composite MSWS-12
scores) from baseline to the end of 2-week training (43.88 ± 8.87 vs. 34.92 ± 10.46,
respectively) (p < 0.001, Cohen’s d = 0.92), as well as from baseline to the end of 6-week
training (43.88 ± 8.87 vs. 31.56 ± 8.37, respectively) (p <0.001, Cohen’s d = 1.43) (Fig 3,
Table 2). There was no statistically significant difference in the composite MSWS-12
score between 2-week training and 6-week training (34.92 ± 10.46 vs. 31.56 ± 8.37,
respectively) (p =0.097, Cohen’s d = 0.35). And there was no significant interaction
between time and group (p = 0.272), suggesting both groups improved their self-reported
gait ability similarly (Fig 3).
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Figure 3: Mean changes in the MSWS-12 raw score at 2 and 6 weeks. MSWS-12: Multiple Sclerosis
Walking Scale-12; TEC: Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p <
0.05

Fatigue measures
There was a statistically significant pre/post main effect (decrease in composite MFIS)
from baseline to 2-week training (62.74 ± 35.14 vs. 41.57 ± 25.92, respectively) (p <
0.001, Cohen’s d = 0.69) and 6-week training (62.74 ± 35.14 vs. 30.26 ± 20.02,
respectively) (p < 0.001, Cohen’s d = 1.14) (Fig 4, Table 2). And there was a significant
difference of the composite MFIS between 2-week training and 6-week training (41.57 ±
25.92 vs. 30.26 ± 20.02, respectively) (p = 0.012, Cohen’s d = 0.49). However, there was
no significant interaction between time and group (p = 0.371), indicating both groups
improved their fatigue (Fig 4).
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Figure 4: Mean changes in the MFIS raw score at 2 and 6 weeks. MFIS: Modified Fatigue Impact Score;
TEC: Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 0.05

QOL measures
There was a significant pre/post main effect (decrease in the composite MSIS-29 scores)
from baseline to the end of 2-week training (76.34 ± 23.38 vs. 57.45 ± 15.55,
respectively) (p < 0.001, Cohen’s d = 0.95), as well as from baseline to the end of 6-week
training (76.34 ± 23.38 vs. 55.94 ± 15.78, respectively) (p < 0.001, Cohen’s d = 1.02)
(Fig 5, Table 2). There was no statistically significant difference regarding the composite
MSIS-29 between 2-week training and 6-week training (57.45 ± 15.55 vs. 55.94 ± 15.78,
respectively) (p = 1.000, Cohen’s d = 0.10). And there was no significant interaction
between time and group (p = 0.835), suggesting both groups improved their QOL
similarly (Fig 5).
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Figure 5: Mean changes in the MSIS-29 raw score at 2 and 6 weeks. MSIS-29: Multiple Sclerosis Impact
Scale; TEC: Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 0.05

Discussion
Our pseudorandomized clinical trial showed that both MAC and TEC groups improved
the balance, gait, fatigue, and QOL in people with MS in a clinically relevant manner.
However, no significant differences were observed between improvements in MAC
group as compared to the TEC group. This effect was evident in the assessment tools,
including DGI, MSWS-12, MFIS, and MSIS-29. The effect was also consistent with the
assessments in our previous study showing the benefits of the high-frequency physical
therapy regarding postural balance and mobility in people with MS.21 Based on the
Cohen’s d criteria, our data suggest a large effect size of improvement in balance, gait,
and QOL, as well as medium effect size of improvement in fatigue only after 2 weeks of
intervention. It also indicates a large effect size of improvement in all outcome measures
after 6 weeks of high-frequency physical therapy.
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Effects on Dynamic Balance
A statistically significant, but a comparable improvement over time at 2-week and 6week periods was observed for dynamic balance according to DGI scores in MAC and
TEC groups. This is contradictory to our hypothesis that the subjects in the MAC would
have greater improvements in the balance than those in the TEC. The minimal detectable
change (MDC) for the DGI is between 4.19 and 5.54 in people with MS.37 Based on this
standard, the composite group at 6 weeks showed a detectable change of DGI score
(mean difference: 4.2 points). The minimal clinically important difference (MCID) has
not been established for MS patients so far. The trend towards improvement of DGI
scores in both groups slowed down after the second week (Fig 1B). We suspect that
participants in both groups would have greater improvements in DGI scores if we
provided them continuing one-on-one training with the physical therapists. Even though
the compliance rate for the both groups was ≥92%, it may have been difficult for
participants to achieve the same effects of the one-on-one training with the therapists
after the second week, especially for the subjects in the MAC, as it required them to
properly adjust the different levels of exercises themselves.
Effects on Gait
The subjects in the study demonstrated a similar significant decrease of 14.33 (30.80%)
and 10.31 (25.01%) points (percentage change) in MSWS-12 at 6-week period in MAC
and TEC groups respectively. This is evident by our DGI findings, as the DGI is also a
clinical tool to assess gait performance in response to changing task demands. Moreover,
it is consistent with our previous result that both MAC and TEC group had similar
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significant improvements in the walking speed and step length in patients with MS.21
There is no MCID established for the MSWS-12, but a study reported the minimal
detectable change (MDC) for the measure was 22 points.99 Although it indicates the
participants’ perception of the change would not be likely to represent a true change in
their gait ability, we suspect that a greater or true improvement would be achieved if our
participants would have continued one-on-one training with the physical therapists after
the second week.
Effects on Fatigue
Fatigue was significantly diminished in both groups, with a 35.33-point (49.48%)
decrease in MAC and a 29.62-point (54.77%) decrease (percentage change) in TEC with
regards to the MFIS total score at the 6-week period. To our knowledge, this is the first
study to demonstrate that the high-frequency physical therapy protocols are beneficial to
improve fatigue in patients with MS. The beneficial effects also exceeded previous
reports from various rehabilitation studies: 55 minutes per session, twice weekly, 6-week
vestibular program (21.5 points, p<0.001),100 30 minutes per session, 3 times weekly, 12week supported treadmill program (13.3 points, p=0.22),101 and 40 minutes per session, 3
times weekly, 12-week mixed exercise program (13.0 points, p=0.02).102 The minimal
detectable change (MDC) for the MFIS was found to be 19.23%,103 while our study
showed an improvement of 49.38% and 54.77% in MAC and TEC at 6 weeks
respectively, suggesting our high-frequency physical therapy protocols may have resulted
in clinically important changes in fatigue as measured by the MFIS. Fatigue is one of the
major factors affecting people with MS. Fatigue can worsen MS other MS-related
symptoms and lead to increased risk of falls. The cause of fatigue in MS is most likely
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multifactorial, including axonal degeneration, demyelination, depression, and physical
inactivity.104 There is cumulating evidence demonstrating that exercise intervention is
safe and it has significant reductions in fatigue in people with MS.20,24 Improvements in
fatigue from our high-frequency physical therapy protocols may result from
improvements in balance, walking ability, and psychosocial variables, such as depression
and mood. Consequently, participants may be able to perform daily tasks in a more
efficient manner at relatively lower intensities, which results in energy conservation and
fatigue improvement.
Effects on QOL
In this study, total MSIS-29 score showed statistically significant improvement for both
groups, but no significant interaction effect between group and time. The MCID values
have not been established for the MSIS-29, but the MDC has been reported to be 8
points.93 The subjects in this study had a mean change of 20.93 (MAC) and 16.85 (TEC)
points in the MSIS-29 after 2-weeks of training with therapists, indicating the
participants’ perception represent a true improvement of the score. However, there was a
minimal improvement of the score during the 4-week home-based training for both
groups. It could be due to the lack of motivation and encouragement directly from
therapists and other participants at home, even though the compliance rate for the homebased training was relatively high for both groups (≥92%). There has been cumulative
evidence to support that physical activity is associated with the improvement of QOL in
patients with MS.95 Several factors have been proposed to be mediators of the physical
activity on QOL in MS, such as physical function, fatigue, mood, and social support.94
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Our high-frequency physical therapy protocol may improve QOL in MS through its
effects on the previous factors and it remains to be explored in future studies.
This study was designed to test if our motor adaptation therapy protocol would yield
better improvements in balance, gait, fatigue, and QOL in people with MS compared with
the therapeutic exercise protocol. After 6-week intervention, both groups showed
significant improvements in balance, gait, fatigue, and QOL, however, no interaction
effects between group and time were found for the aforementioned factors. Since both
cohorts completed different training protocols at the same frequency, a high-frequency
physical therapy protocol might be an effective and efficient dosage parameter for the
rehabilitation of individuals with MS.

Limitations
There are a few limitations in the present study. First, our clinical investigation was based
on a relatively small sample size to differentiate the treatment effects between the two
groups. However, the large effect size of the improvements in clinical measures suggests
that the findings are less likely to be affected by sample size. A larger sample size could
improve the generalizability of our findings. Second, there is variability in the level of
disability of participants with MS from moderate to severe. We limited the subjects’
EDSS from 3.0 to 6.5. There was no significant difference between two groups with
regard to the participants’ mean score of the EDSS at baseline.

However, a more

homogenous subset of participants according to the severity of disability may have
produced different outcomes. And the benefits of high-frequency physical therapy
training for patients with more severe disability (EDSS > 6.5) require further
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investigation. Third, there is a lack of a controlled group trained at a normal-dosage or
less-frequent physical therapy. It would be of help to explore if the high frequency of the
physical therapy has a ceiling effect, or if there is a different treatment effect between two
different protocols at a typical-dosage level of physical therapy. Finally, we did not
perform a follow-up study to determine whether the treatment effect would maintain after
the intervention. Subsequent investigations on long-term effectiveness of the highfrequency physical therapy in people with MS would be desirable.

Conclusions
Our study shows both motor adaptation exercises and traditional exercises had a
significant, but similar treatment effect for primary outcomes after 6-week physical
therapy intervention. Our results provide evidence that a high-frequency physical therapy
intervention consisting of twice per day and five days per week sessions may be an
important parameter for improving balance, gait, fatigue, and QOL in people with MS.
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